US 10426797
Compositions and methods for treating cancer with anti-CD33 immunotherapy
granted A61KA61K2039/505A61K2239/25
Quick answer
US patent 10426797 (Compositions and methods for treating cancer with anti-CD33 immunotherapy) held by United State of America, As Represented by the Secretary, Dept. of Health and Human Services expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United State of America, As Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2239/25, A61K2239/38, A61K39/39558